GenieBiome Limited – Trademark Portfolio
Entity Type: 99
GenieBiome Limited holds 18 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 15 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 10 trademarks are registered and 7 are pending. Notable registered marks include HQP, MQU, SCV09, SGR11, and G-NIIB. The owner is based in Wanchai.
208 Johnston Road
Flat/Room 1201, 12/F,
Wanchai , HK
Showing of trademarks Trademarks
Trademark Classifications
GenieBiome Limited's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does GenieBiome Limited have?
GenieBiome Limited has 18 U.S. trademarks filed with the USPTO. Of these, 10 registered, 7 pending, 1 abandoned.
What trademark classes does GenieBiome Limited file in?
GenieBiome Limited files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are GenieBiome Limited's most well-known trademarks?
GenieBiome Limited's registered trademark portfolio includes well-known marks such as HQP, MQU, SCV09, SGR11, and G-NIIB. These are among 10 currently registered trademarks in the portfolio.
What is GenieBiome Limited's trademark registration success rate?
GenieBiome Limited has a 91% trademark registration rate, with 10 out of 11 resolved applications resulting in successful registration. Currently, 7 applications are pending review.